Atlas Trials

Effects of Ipragliflozin on Excessive Fat in Type 2 Diabetes Patients With Non-alcoholic Fatty Liver Disease Treated With Metformin and Pioglitazone

Clinical trial NCT02875821 · COMPLETED

Trial details

NCT number
NCT02875821
Sponsor
Yonsei University
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Type 2 Diabetes With Non-alcoholic Fatty Liver (NAFLD)
Start date
2016-04-26
Primary completion
2017-06-07
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.